General Anesthetic for Surgery - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB511243973

Publication Date:

November 26, 2024

Pages:

124

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management. General anesthesia is used in various cardiac surgeries, hip and knee replacement surgeries, cancer surgeries, and gastro-intestinal surgeries.
The global market for General Anesthetic for Surgery was estimated to be worth US$ 3926 million in 2023 and is forecast to a readjusted size of US$ 4983.4 million by 2030 with a CAGR of 3.5% during the forecast period 2024-2030
The general anesthetic for surgery market is primarily driven by the increasing number of surgical procedures performed globally and the growing demand for safe and effective anesthesia to ensure patient comfort and successful surgical outcomes. General anesthesia plays a crucial role in inducing a reversible state of unconsciousness and analgesia during surgery, allowing surgeons to perform complex procedures with minimal patient discomfort. Moreover, advancements in anesthesia delivery systems and monitoring technologies contribute to the market's growth by enhancing anesthesia administration precision and patient safety. However, the market also faces challenges, including the potential for adverse reactions and complications associated with general anesthesia, such as postoperative nausea and vomiting (PONV) or rare anesthetic-related reactions. Ensuring patient safety and minimizing the risk of adverse events remain key challenges for healthcare providers and anesthesiologists. Additionally, the availability and accessibility of anesthesia services in remote or underserved regions can be limited, hindering access to surgical care for some patients.
Report Scope
This report aims to provide a comprehensive presentation of the global market for General Anesthetic for Surgery, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of General Anesthetic for Surgery by region & country, by Type, and by Application.
The General Anesthetic for Surgery market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding General Anesthetic for Surgery.
麻豆原创 Segmentation
By Company
Aspen Pharma
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Maruishi
Piramal
Hikma Pharmaceuticals
Yichang Humanwell
Nhwa
Hengrui
Xi'an Libang
Segment by Type:
Propofol
Sevoflurane
Remifentanil
Etomidate
Isoflurane
Other
Segment by Application
Intravenous Anesthetics
Inhalational Anesthetics
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of General Anesthetic for Surgery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of General Anesthetic for Surgery in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of General Anesthetic for Surgery in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 General Anesthetic for Surgery Product Introduction
1.2 Global General Anesthetic for Surgery 麻豆原创 Size Forecast
1.2.1 Global General Anesthetic for Surgery Sales Value (2019-2030)
1.2.2 Global General Anesthetic for Surgery Sales Volume (2019-2030)
1.2.3 Global General Anesthetic for Surgery Sales Price (2019-2030)
1.3 General Anesthetic for Surgery 麻豆原创 Trends & Drivers
1.3.1 General Anesthetic for Surgery Industry Trends
1.3.2 General Anesthetic for Surgery 麻豆原创 Drivers & Opportunity
1.3.3 General Anesthetic for Surgery 麻豆原创 Challenges
1.3.4 General Anesthetic for Surgery 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global General Anesthetic for Surgery Players Revenue Ranking (2023)
2.2 Global General Anesthetic for Surgery Revenue by Company (2019-2024)
2.3 Global General Anesthetic for Surgery Players Sales Volume Ranking (2023)
2.4 Global General Anesthetic for Surgery Sales Volume by Company Players (2019-2024)
2.5 Global General Anesthetic for Surgery Average Price by Company (2019-2024)
2.6 Key Manufacturers General Anesthetic for Surgery Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers General Anesthetic for Surgery Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of General Anesthetic for Surgery
2.9 General Anesthetic for Surgery 麻豆原创 Competitive Analysis
2.9.1 General Anesthetic for Surgery 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by General Anesthetic for Surgery Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in General Anesthetic for Surgery as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Propofol
3.1.2 Sevoflurane
3.1.3 Remifentanil
3.1.4 Etomidate
3.1.5 Isoflurane
3.1.6 Other
3.2 Global General Anesthetic for Surgery Sales Value by Type
3.2.1 Global General Anesthetic for Surgery Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global General Anesthetic for Surgery Sales Value, by Type (2019-2030)
3.2.3 Global General Anesthetic for Surgery Sales Value, by Type (%) (2019-2030)
3.3 Global General Anesthetic for Surgery Sales Volume by Type
3.3.1 Global General Anesthetic for Surgery Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global General Anesthetic for Surgery Sales Volume, by Type (2019-2030)
3.3.3 Global General Anesthetic for Surgery Sales Volume, by Type (%) (2019-2030)
3.4 Global General Anesthetic for Surgery Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Intravenous Anesthetics
4.1.2 Inhalational Anesthetics
4.2 Global General Anesthetic for Surgery Sales Value by Application
4.2.1 Global General Anesthetic for Surgery Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global General Anesthetic for Surgery Sales Value, by Application (2019-2030)
4.2.3 Global General Anesthetic for Surgery Sales Value, by Application (%) (2019-2030)
4.3 Global General Anesthetic for Surgery Sales Volume by Application
4.3.1 Global General Anesthetic for Surgery Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global General Anesthetic for Surgery Sales Volume, by Application (2019-2030)
4.3.3 Global General Anesthetic for Surgery Sales Volume, by Application (%) (2019-2030)
4.4 Global General Anesthetic for Surgery Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global General Anesthetic for Surgery Sales Value by Region
5.1.1 Global General Anesthetic for Surgery Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global General Anesthetic for Surgery Sales Value by Region (2019-2024)
5.1.3 Global General Anesthetic for Surgery Sales Value by Region (2025-2030)
5.1.4 Global General Anesthetic for Surgery Sales Value by Region (%), (2019-2030)
5.2 Global General Anesthetic for Surgery Sales Volume by Region
5.2.1 Global General Anesthetic for Surgery Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global General Anesthetic for Surgery Sales Volume by Region (2019-2024)
5.2.3 Global General Anesthetic for Surgery Sales Volume by Region (2025-2030)
5.2.4 Global General Anesthetic for Surgery Sales Volume by Region (%), (2019-2030)
5.3 Global General Anesthetic for Surgery Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America General Anesthetic for Surgery Sales Value, 2019-2030
5.4.2 North America General Anesthetic for Surgery Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe General Anesthetic for Surgery Sales Value, 2019-2030
5.5.2 Europe General Anesthetic for Surgery Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific General Anesthetic for Surgery Sales Value, 2019-2030
5.6.2 Asia Pacific General Anesthetic for Surgery Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America General Anesthetic for Surgery Sales Value, 2019-2030
5.7.2 South America General Anesthetic for Surgery Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa General Anesthetic for Surgery Sales Value, 2019-2030
5.8.2 Middle East & Africa General Anesthetic for Surgery Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions General Anesthetic for Surgery Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions General Anesthetic for Surgery Sales Value
6.2.1 Key Countries/Regions General Anesthetic for Surgery Sales Value, 2019-2030
6.2.2 Key Countries/Regions General Anesthetic for Surgery Sales Volume, 2019-2030
6.3 United States
6.3.1 United States General Anesthetic for Surgery Sales Value, 2019-2030
6.3.2 United States General Anesthetic for Surgery Sales Value by Type (%), 2023 VS 2030
6.3.3 United States General Anesthetic for Surgery Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe General Anesthetic for Surgery Sales Value, 2019-2030
6.4.2 Europe General Anesthetic for Surgery Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe General Anesthetic for Surgery Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China General Anesthetic for Surgery Sales Value, 2019-2030
6.5.2 China General Anesthetic for Surgery Sales Value by Type (%), 2023 VS 2030
6.5.3 China General Anesthetic for Surgery Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan General Anesthetic for Surgery Sales Value, 2019-2030
6.6.2 Japan General Anesthetic for Surgery Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan General Anesthetic for Surgery Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea General Anesthetic for Surgery Sales Value, 2019-2030
6.7.2 South Korea General Anesthetic for Surgery Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea General Anesthetic for Surgery Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia General Anesthetic for Surgery Sales Value, 2019-2030
6.8.2 Southeast Asia General Anesthetic for Surgery Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia General Anesthetic for Surgery Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India General Anesthetic for Surgery Sales Value, 2019-2030
6.9.2 India General Anesthetic for Surgery Sales Value by Type (%), 2023 VS 2030
6.9.3 India General Anesthetic for Surgery Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Aspen Pharma
7.1.1 Aspen Pharma Company Information
7.1.2 Aspen Pharma Introduction and Business Overview
7.1.3 Aspen Pharma General Anesthetic for Surgery Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Aspen Pharma General Anesthetic for Surgery Product Offerings
7.1.5 Aspen Pharma Recent Development
7.2 Fresenius-Kabi
7.2.1 Fresenius-Kabi Company Information
7.2.2 Fresenius-Kabi Introduction and Business Overview
7.2.3 Fresenius-Kabi General Anesthetic for Surgery Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Fresenius-Kabi General Anesthetic for Surgery Product Offerings
7.2.5 Fresenius-Kabi Recent Development
7.3 AbbVie
7.3.1 AbbVie Company Information
7.3.2 AbbVie Introduction and Business Overview
7.3.3 AbbVie General Anesthetic for Surgery Sales, Revenue and Gross Margin (2019-2024)
7.3.4 AbbVie General Anesthetic for Surgery Product Offerings
7.3.5 AbbVie Recent Development
7.4 Baxter Healthcare
7.4.1 Baxter Healthcare Company Information
7.4.2 Baxter Healthcare Introduction and Business Overview
7.4.3 Baxter Healthcare General Anesthetic for Surgery Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Baxter Healthcare General Anesthetic for Surgery Product Offerings
7.4.5 Baxter Healthcare Recent Development
7.5 B.Braun
7.5.1 B.Braun Company Information
7.5.2 B.Braun Introduction and Business Overview
7.5.3 B.Braun General Anesthetic for Surgery Sales, Revenue and Gross Margin (2019-2024)
7.5.4 B.Braun General Anesthetic for Surgery Product Offerings
7.5.5 B.Braun Recent Development
7.6 Maruishi
7.6.1 Maruishi Company Information
7.6.2 Maruishi Introduction and Business Overview
7.6.3 Maruishi General Anesthetic for Surgery Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Maruishi General Anesthetic for Surgery Product Offerings
7.6.5 Maruishi Recent Development
7.7 Piramal
7.7.1 Piramal Company Information
7.7.2 Piramal Introduction and Business Overview
7.7.3 Piramal General Anesthetic for Surgery Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Piramal General Anesthetic for Surgery Product Offerings
7.7.5 Piramal Recent Development
7.8 Hikma Pharmaceuticals
7.8.1 Hikma Pharmaceuticals Company Information
7.8.2 Hikma Pharmaceuticals Introduction and Business Overview
7.8.3 Hikma Pharmaceuticals General Anesthetic for Surgery Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Hikma Pharmaceuticals General Anesthetic for Surgery Product Offerings
7.8.5 Hikma Pharmaceuticals Recent Development
7.9 Yichang Humanwell
7.9.1 Yichang Humanwell Company Information
7.9.2 Yichang Humanwell Introduction and Business Overview
7.9.3 Yichang Humanwell General Anesthetic for Surgery Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Yichang Humanwell General Anesthetic for Surgery Product Offerings
7.9.5 Yichang Humanwell Recent Development
7.10 Nhwa
7.10.1 Nhwa Company Information
7.10.2 Nhwa Introduction and Business Overview
7.10.3 Nhwa General Anesthetic for Surgery Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Nhwa General Anesthetic for Surgery Product Offerings
7.10.5 Nhwa Recent Development
7.11 Hengrui
7.11.1 Hengrui Company Information
7.11.2 Hengrui Introduction and Business Overview
7.11.3 Hengrui General Anesthetic for Surgery Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Hengrui General Anesthetic for Surgery Product Offerings
7.11.5 Hengrui Recent Development
7.12 Xi'an Libang
7.12.1 Xi'an Libang Company Information
7.12.2 Xi'an Libang Introduction and Business Overview
7.12.3 Xi'an Libang General Anesthetic for Surgery Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Xi'an Libang General Anesthetic for Surgery Product Offerings
7.12.5 Xi'an Libang Recent Development
8 Industry Chain Analysis
8.1 General Anesthetic for Surgery Industrial Chain
8.2 General Anesthetic for Surgery Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 General Anesthetic for Surgery Sales Model
8.5.2 Sales Channel
8.5.3 General Anesthetic for Surgery Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Aspen Pharma
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Maruishi
Piramal
Hikma Pharmaceuticals
Yichang Humanwell
Nhwa
Hengrui
Xi'an Libang

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.